StockData
LifeStance Health Group, Inc. logo

LifeStance Health Group, Inc. (LFST) stock

LFSTNasdaqServices-Health ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/30243% above fair value
$14.17−0.31 (-2.14%)

Close on Nov 17, 2026Market cap $5.41BP/E 109.0Yield –

LifeStance Health revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

LifeStance Health's revenue for the twelve months ending Jun 30, 2026 was $1.58B, up 20.4% year over year. For fiscal 2025 it was $1.42B, up 13.9% from the year before. The highest annual figure on record is $1.42B in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.42B+13.9%
FY2024Dec 31, 2024$1.25B+18.5%
FY2023Dec 31, 2023$1.06B+22.8%
FY2022Dec 31, 2022$859.54M+28.8%
FY2021Dec 31, 2021$667.51M+214.1%
FY2019Dec 31, 2019$212.52M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$435.35M+26.1%
Q1 FY2026Mar 31, 2026$403.48M+21.2%
Q4 FY2025Dec 31, 2025$382.20M+17.4%
Q3 FY2025Sep 30, 2025$363.81M+16.3%
Q2 FY2025Jun 30, 2025$345.31M+10.6%
Q1 FY2025Mar 31, 2025$332.97M+10.8%
Q4 FY2024Dec 31, 2024$325.48M+16.0%
Q3 FY2024Sep 30, 2024$312.72M+19.0%
Q2 FY2024Jun 30, 2024$312.33M+20.3%
Q1 FY2024Mar 31, 2024$300.44M+18.9%
Q4 FY2023Dec 31, 2023$280.60M+22.3%
Q3 FY2023Sep 30, 2023$262.90M+20.8%
Q2 FY2023Jun 30, 2023$259.58M+23.9%
Q1 FY2023Mar 31, 2023$252.59M+24.4%
Q4 FY2022Dec 31, 2022$229.36M+20.7%
Q3 FY2022Sep 30, 2022$217.56M+25.2%
Q2 FY2022Jun 30, 2022$209.53M+30.5%
Q1 FY2022Mar 31, 2022$203.10M+41.9%
Q4 FY2021Dec 31, 2021$190.00M+86.3%
Q3 FY2021Sep 30, 2021$173.84M+282.5%
Q2 FY2021Jun 30, 2021$160.55M–
Q1 FY2021Mar 31, 2021$143.13M–
Q3 FY2020Sep 30, 2020$101.98M–
Q2 FY2020Jun 30, 2020$45.45M–

More LifeStance Health figures

See a number that looks wrong?